A. Geser

1.4k total citations · 1 hit paper
20 papers, 1.0k citations indexed

About

A. Geser is a scholar working on Oncology, Pathology and Forensic Medicine and Immunology. According to data from OpenAlex, A. Geser has authored 20 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Oncology, 11 papers in Pathology and Forensic Medicine and 5 papers in Immunology. Recurrent topics in A. Geser's work include Viral-associated cancers and disorders (13 papers), Lymphoma Diagnosis and Treatment (11 papers) and T-cell and Retrovirus Studies (5 papers). A. Geser is often cited by papers focused on Viral-associated cancers and disorders (13 papers), Lymphoma Diagnosis and Treatment (11 papers) and T-cell and Retrovirus Studies (5 papers). A. Geser collaborates with scholars based in France, United States and Uganda. A. Geser's co-authors include Edward H. Williams, G de-Thé, P. M. Tukei, Peter G. Smith, Nicholas Day, Andrew G. Dean, Werner Henle, Paul M. Feorino, J Wahrendorf and Ole Møller Jensen and has published in prestigious journals such as Nature, The Lancet and American Journal of Epidemiology.

In The Last Decade

A. Geser

18 papers receiving 937 citations

Hit Papers

Epidemiological evidence ... 1978 2026 1994 2010 1978 100 200 300 400

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
A. Geser 682 376 248 229 186 20 1.0k
J C Guillaume 375 0.5× 310 0.8× 262 1.1× 187 0.8× 216 1.2× 44 1.2k
Domenico Pastore 379 0.6× 123 0.3× 205 0.8× 119 0.5× 210 1.1× 66 1.3k
Steve Kamiza 337 0.5× 198 0.5× 226 0.9× 124 0.5× 590 3.2× 39 1.3k
Andrea Mengarelli 279 0.4× 79 0.2× 161 0.6× 164 0.7× 114 0.6× 64 1.0k
William Kopp 280 0.4× 186 0.5× 203 0.8× 54 0.2× 68 0.4× 26 978
J Icart 384 0.6× 159 0.4× 348 1.4× 226 1.0× 25 0.1× 37 805
James Kitinya 233 0.3× 95 0.3× 222 0.9× 150 0.7× 98 0.5× 47 765
Judith Brody 193 0.3× 242 0.6× 124 0.5× 66 0.3× 44 0.2× 45 778
Richard Champlin 325 0.5× 70 0.2× 299 1.2× 259 1.1× 197 1.1× 32 1.5k
Nitin Gangane 303 0.4× 111 0.3× 221 0.9× 90 0.4× 103 0.6× 97 996

Countries citing papers authored by A. Geser

Since Specialization
Citations

This map shows the geographic impact of A. Geser's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Geser with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Geser more than expected).

Fields of papers citing papers by A. Geser

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Geser. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Geser. The network helps show where A. Geser may publish in the future.

Co-authorship network of co-authors of A. Geser

This figure shows the co-authorship network connecting the top 25 collaborators of A. Geser. A scholar is included among the top collaborators of A. Geser based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. Geser. A. Geser is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Day, N E, A. Geser, J. H. C. Ho, et al.. (2015). Epidemiology of the Epstein-Barr Virus Infection and Associated Tumors in Man. Proceedings of the International Symposium on Comparative Leukemia Research. 216–220. 3 indexed citations
2.
Geser, A., et al.. (2015). A Prospective Sero-Epidemiological Study to Investigate the Role of EBV in Burkitt�s Lymphoma1. Proceedings of the International Symposium on Comparative Leukemia Research. 39. 448–456.
3.
Draper, C. C., G. Brubaker, A. Geser, V.A.E.B. Kilimali, & W. H. Wernsdorfer. (1985). Serial studies on the evolution of chloroquine resistance in an area of East Africa receiving intermittent malaria chemosuppression.. PubMed. 63(1). 109–18. 35 indexed citations
4.
Geser, A. & G. Brubaker. (1985). A preliminary report of epidemiological studies of Burkitt's lymphoma, Epstein-Barr virus infection and malaria in North Mara, Tanzania.. PubMed. 205–15. 7 indexed citations
5.
McHardy, Jolian, Edward H. Williams, A. Geser, et al.. (1984). Endemic Kaposi's sarcoma: Incidence and risk factors in the west Nile district Of Uganda. International Journal of Cancer. 33(2). 203–212. 36 indexed citations
6.
Jensen, Ole Møller, et al.. (1984). THE RELIABILITY OF QUESTIONNAIRE-DERIVED HISTORICAL DIETARY INFORMATION AND TEMPORAL STABILITY OF FOOD HABITS IN INDIVIDUALS. American Journal of Epidemiology. 120(2). 281–290. 142 indexed citations
7.
Geser, A., Guy de Thé, Gilbert Lenoir, N E Day, & Edward H. Williams. (1982). Final case reporting from the ugandan prospective study of the relationship between ebv and burktit's lymphoma. International Journal of Cancer. 29(4). 397–400. 98 indexed citations
8.
Siemiatycki, Jack, G. Brubaker, & A. Geser. (1980). Space‐time clustering of Burkitt's lymphoma in East Africa: Analysis of recent data and a new look at old data. International Journal of Cancer. 25(2). 197–203. 16 indexed citations
9.
Geser, A., et al.. (1980). The frequency of Epstein-Barr virus infection and Burkitt's lymphoma at high and low altitudes in East Africa.. PubMed. 28(3). 307–21. 7 indexed citations
10.
Geser, A., et al.. (1978). Environmental factors in the etiology of nasopharyngeal carcinoma: report on a case-control study in Hong Kong.. PubMed. 213–29. 48 indexed citations
11.
de-Thé, G, A. Geser, Nicholas Day, et al.. (1978). Epidemiological evidence for causal relationship between Epstein-Barr virus and Burkitt's lymphoma from Ugandan prospective study. Nature. 274(5673). 756–761. 419 indexed citations breakdown →
12.
Williams, Edward H., et al.. (1978). Space-time clustering of Burkitt's lymphoma in the West Nile district of Uganda: 1961–1975. British Journal of Cancer. 37(1). 109–122. 36 indexed citations
13.
de-Thé, G, Day Ne, A. Geser, et al.. (1975). Sero-epidemiology of the Epstein-Barr virus: preliminary analysis of an international study - a review.. PubMed. 3–16. 99 indexed citations
14.
Day, N E, et al.. (1974). SEASONAL VARIATION IN ONSET OF BURKITT'S LYMPHOMA IN THE WEST NILE DISTRICT OF UGANDA. The Lancet. 304(7871). 19–22. 18 indexed citations
15.
Geser, A., Nicholas Day, G de-Thé, et al.. (1974). The variability in immunofluorescent viral capsid antigen antibody tests in population surveys of Epstein-Barr virus infections.. PubMed. 50(5). 389–400. 5 indexed citations
16.
Sohier, R, et al.. (1974). SEROEPIDEMIOLOGY OF HERPESVIRUS TYPE EPSTEIN-BARR IN BLOOD DONORS FROM COMMUNITIES AROUND LYON1. American Journal of Epidemiology. 99(6). 414–424. 2 indexed citations
17.
Brubaker, G., A. Geser, & Malcolm C. Pike. (1973). Burkitt's lymphoma in the North Mara district of Tanzania 1964-70: failure to find evidence of time-space clustering in a high risk isolated rural area. British Journal of Cancer. 28(5). 469–472. 14 indexed citations
18.
Zykov, M. P., et al.. (1966). A serological test in tuberculosis. A "blind" trial of the kaolin-agglutination test (KAT) for detection of tuberculosis antibodies.. PubMed. 35(4). 581–92. 1 indexed citations
19.
Narain, Raj, et al.. (1963). SOME ASPECTS OF A TUBERCULOSIS PREVALENCE SURVEY IN A SOUTH INDIAN DISTRICT.. PubMed. 29. 641–64. 25 indexed citations
20.
Narain, Raj, et al.. (1963). Tuberculosis prevalence survey in Tumkur district. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026